Procaps Group S.A. (NASDAQ:PROC) Short Interest Update

Procaps Group S.A. (NASDAQ:PROC) was the recipient of a significant decline in short interest in December. As of December 31st, there was short interest totalling 133,300 shares, a decline of 18.4% from the December 15th total of 163,300 shares. Based on an average daily volume of 98,600 shares, the short-interest ratio is presently 1.4 days. Approximately 0.1% of the company’s stock are sold short.

Procaps Group Stock Up 0.6 %

PROC opened at $1.75 on Friday. The company has a fifty day moving average price of $1.85 and a two-hundred day moving average price of $2.01. Procaps Group has a 1-year low of $0.50 and a 1-year high of $4.50.

About Procaps Group

Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.